NDC 0002-4491

Reyvow

Lasmiditan

Reyvow is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Lasmiditan.

• Product ID: 0002-4491_1ba572bf-50d9-45aa-b2fb-533be8ea0e38
• NDC: 0002-4491
• Product Type: Human Prescription Drug
• Proprietary Name: Reyvow
• Generic Name: Lasmiditan
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2019-10-11
• Marketing Category: NDA / NDA
• Application Number: NDA211280
• Labeler Name: Eli Lilly and Company
• Substance Name: LASMIDITAN
• Active Ingredient Strength: 100 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0002-4491-08

2 BLISTER PACK in 1 CARTON (0002-4491-08) > 4 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2020-01-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-4491-08 [00002449108]

Reyvow TABLET

• Marketing Category: NDA
• Application Number: NDA211280
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2020-01-31

NDC 0002-4491-61 [00002449161]

Reyvow TABLET

• Marketing Category: NDA
• Application Number: NDA211280
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
LASMIDITAN	100 mg/1

NDC Crossover Matching brand name "Reyvow" or generic name "Lasmiditan"

NDC	Brand Name	Generic Name
0002-4312	Reyvow	lasmiditan
0002-4491	Reyvow	lasmiditan
0002-4736	Reyvow	lasmiditan